1. Introduction {#sec1-molecules-22-00912}
===============

*Tinospora sinensis* (Kuanjinteng in Chinese) is commonly known as 'Gurch' and belongs to the family Menispermaceae, which is mainly distributed in the tropical parts of the eastern hemisphere. It has been traditionally used as folk medicine for treating debility, dyspepsia, rheumatism, gonorrhea, fever, inflammation, syphilis, ulcer, bronchitis, jaundice, urinary disease, skin disease and liver disease \[[@B1-molecules-22-00912],[@B2-molecules-22-00912],[@B3-molecules-22-00912]\]. Previous phytochemical investigations have discovered that this species contains diterpenoids, alkaloids, flavonoids, lignans, triterpenes, amino acids, and so on. These constituents were reported to exert anti-inflammatory, immunomodulatory, antidiabetic, antitumor, antiadhesive, antiviral, anti-infective, antioxidant, antimutagenic, hematopoietic activities, etc. \[[@B4-molecules-22-00912],[@B5-molecules-22-00912],[@B6-molecules-22-00912],[@B7-molecules-22-00912],[@B8-molecules-22-00912]\]. To our best knowledge, few reports on the systematic analysis of the diterpenoids in *T. sinensis* are available until now.

Recently, with the development of various data acquisition methods, high-resolution mass spectrometry (HRMS), especially linear ion trap-Orbitrap mass spectrometer (LTQ-Orbitrap), has exhibited excellent performance in the detection of targeted mixture constituents owing to its high speed and detection sensitivity \[[@B9-molecules-22-00912],[@B10-molecules-22-00912]\]. The hybrid linear ion trap-Orbitrap mass spectrometer (LTQ-Orbitrap MS) combines high trapping capacity and MS^n^ scanning function of a linear ion trap together with accurate mass measurements within 3 ppm. The resolution power (up to 100,000) over a wider dynamic range is superior to that of many other mass spectrometers \[[@B11-molecules-22-00912],[@B12-molecules-22-00912],[@B13-molecules-22-00912]\]. In the meantime, the combined application of tandem mass spectrometry for identifying the complicated constituents in traditional Chinese medicines (TCMs) could produce a large quantity of information data, such as molecular weights, elemental compositions, fragmentation patterns of multiple-stage, etc. \[[@B10-molecules-22-00912]\]. Off-line processing of data, such as extracted ion chromatogram (EIC) data-mining method, plays a vital role in component identification \[[@B14-molecules-22-00912],[@B15-molecules-22-00912]\]. These advantages have made LTQ-Orbitrap MS one of the most powerful approaches for the rapid identification and characterization of the multiple constituents found in TCMs \[[@B16-molecules-22-00912]\]. It is well known that studies on flavonoids and alkaloids in *T. sinensis* by LC-MS have been widely reported, but little attention has been paid to its diterpenoids, mainly due to the complexity and variety of their skeletons, the diversity of their substituents, and a lack of corresponding reference standards. Hence, the characterization of diterpenoids in *T. sinensis* is of great significance.

In the present study, an HPLC-LTQ-Orbitrap data-acquisition approach combined with the EIC data-mining technique was established for comprehensive identification of the diterpenoids and their derivatives in *T. sinensis*.

2. Results and Discussion {#sec2-molecules-22-00912}
=========================

Owing to the low content of diterpenoids in *T. sinensis*, a sensitive and reliable HPLC-LTQ-Orbitrap approach was established for determining their accurate masses and molecular formulas. In addition, the characteristic fragmentation pathways of diterpenoids were deduced from two obtained standards, and then used for the rapid identification and characterization of the other diterpenoids in *T. sinensis*. Furthermore, diterpenoid isomers were differentiated by an important parameter, Clog *P*, which is the absolute numerical value of the distribution coefficient of substances in a two-phase lipid-water system. Finally, target isolation of one diterpenoid glycoside named tinosineside A was performed based on the obtained results, which further confirmed the deduced fragmentation patterns. As a result, a total of 63 diterpenoids in *T. sinensis* were screened and divided into diterpenoid aglycones and diterpenoid glycosides (see [supplementary materials](#app1-molecules-22-00912){ref-type="app"} and [Table 1](#molecules-22-00912-t001){ref-type="table"}).

2.1. The Fragmentation Patterns of Reference Standards {#sec2dot1-molecules-22-00912}
------------------------------------------------------

Columbin and isocolumbin yielded their \[M − H\]^−^ ions at *m*/*z* 357.13326 (C~20~H~21~O~6~). Both of their deprotonated molecular ions generated a serial of fragment ions at *m*/*z* 342, *m*/*z* 339, *m*/*z* 313 and *m*/*z* 295, corresponding to \[M − H − CH~3~\]^−^, \[M − H − H~2~O\]^−^, \[M − H − CO~2~\]^−^ and \[M − H − H~2~O − CO~2~\]^−^. Columbin produced a fragment ion at *m*/*z* 329 through losing carbonyl, and the ion at *m*/*z* 329 loss of a CO~2~ produced its ESI-MS^2^ base peak ion at *m*/*z* 285. The ion at *m*/*z* 245 \[M − H − 112\]^−^ resulted from a Retro-Diels-Alder (RDA) cleavage fragmentation at the 1,4-position of the A-ring. Moreover, the product ion at *m*/*z* 245 generated the minor ion at *m*/*z* 217 by loss of one molecule of CO.

Meanwhile, isocolumbin produced its ESI-MS^2^ base peak ion at *m*/*z* 339 by neutral loss of H~2~O. After a RDA cleavage at A-ring and successive fracture of C~9--11~ (C~6~H~6~O, which was D-ring plus --C~2~H~2~), the prominent ion at *m*/*z* 151 was generated ([Figure 1](#molecules-22-00912-f001){ref-type="fig"}). Therefore, the characteristic fragment ions of reference standards were deduced, such as \[M − H − 44\]^−^ generated by loss of CO~2~ from lactone ring, as well as \[M − H − 15\]^−^, \[M − H − 18\]^−^, \[M − H − 44 − 18\]^−^, \[M − H − 112\]^−^, etc., According to these characteristic fragmentation patterns, diterpenoids in *T. sinensis* could be rapidly screened and identified.

2.2. Identification of Diterpenoids Aglycones {#sec2dot2-molecules-22-00912}
---------------------------------------------

The molecular formulas of diterpenoids were predicted by a HRMS database built in-house. Combined with multi-stage mass spectrometry fragmentation information and bibliographic data, two categories of diterpenoids and its derivatives were screened and determined, including 10 diterpenoid aglycones and 53 diterpenoid glycosides. The typical total ion chromatogram (TIC) of *T. sinensis* in negative ion mode is presented in [Figure 2](#molecules-22-00912-f002){ref-type="fig"}.

Compounds **29** and **51** generated their \[M − H\]^−^ ions at *m*/*z* 357.13326 (C~20~H~21~O~6~). They were unambiguously assigned as isocolumbin and columbin, respectively, by comparison of their retention times, literature data and MS fragmentation data with their standards \[[@B17-molecules-22-00912],[@B18-molecules-22-00912]\]. Isocolumbin and columbin constitute a pair of diastereomers, whose retention time and polarity are different under the present chromatographic conditions.

Compound **32** produced its \[M − H\]^−^ ion at *m*/*z* 417.15439 (C~22~H~25~O~8~). In CID mode, it further generated \[M − H − CH~3~\]^−^, \[M − H − H~2~O − CO\]^−^ and \[M − H − H~2~O − CO − CH~3~\]^−^ ion at *m*/*z* 402, *m*/*z* 371 and *m*/*z* 356, respectively. The ESI-MS^2^ base peak ion at *m*/*z* 181 (C~11~H~17~O~2~) was generated by RDA cleavage fragmentation from 1,4-position of the A-ring and fracture of C~9--11~ (C~6~H~4~O~3~). The product ion at *m*/*z* 181 loss of a methyl generated the prominent ion at *m*/*z* 166. Therefore, compound **32** was tentatively deduced as tinocapilactone B \[[@B19-molecules-22-00912]\].

Compounds **40** and **41** produced their \[M − H\]^−^ ions at *m*/*z* 373.12817 (C~20~H~21~O~7~). Both of their deprotonated molecular ions generated a series of fragment ions at *m*/*z* 358 \[M − H − CH~3~\]^−^, *m*/*z* 343 \[M − H − CO − H~2~\]^−^, *m*/*z* 325 \[M − H − 48 amu\]^−^ and *m*/*z* 313 \[M − H − 60 amu\]^−^, respectively. In addition, compound **41** generated two minor ions at *m*/*z* 305 and *m*/*z* 261. By comparison with the MS fragmentation patterns obtained from the reference standards, compounds **40** and **41** were plausibly characterized as 8-hydroxycolumbin and 6-hydroxycolumbin, respectively.

Compound **57** showed the \[M − H\]^−^ ion at *m*/*z* 329.13835 (C~19~H~21~O~5~). Its ESI-MS^2^ base peak ion at *m*/*z* 314 was generated by loss of a methyl. The major fragment ions at *m*/*z* 311 and *m*/*z* 285 were yielded by neutral loss of H~2~O and CO~2~, respectively. Moreover, the product ion at *m*/*z* 285 generated the predominant product ion at *m*/*z* 191 due to the overall fracture of C~9--11~ (C~6~H~6~O). According to the literature data, it was tentatively identified as tinosponone \[[@B20-molecules-22-00912]\].

Compounds **60** and **61** produced their respective \[M − H\]^−^ ion at *m*/*z* 329.17473 (C~20~H~25~O~4~) and *m*/*z* 347.18530 (C~20~H~27~O~5~). Both of their deprotonated molecular ions generated \[M − H − H~2~O\]^−^, \[M − H − CO~2~\]^−^ and \[M − H − H~2~O − CO~2~\]^−^ ions at *m*/*z* 311, *m*/*z* 329, *m*/*z* 285, *m*/*z* 303 and *m*/*z* 267, *m*/*z* 285, respectively. By comparing with the literature data, compounds **60** and **61** were tentatively identified as tinotufolin D and (2aβ,3*α*,5aβ,6β,7*α*,8a*α*)-6-2-(3-furanyl)ethyl-2a,3,4,5,5a,6,7,8,8a,8b- decahydro-2a,3-dihydroxy-6,7,8b-trimethyl-2*H*-naphtho-1,8-bcfuran-2-one, respectively \[[@B21-molecules-22-00912]\].

Compound **62** gave a \[M − H\]^−^ ion at *m*/*z* 331.19038 (C~20~H~27~O~4~). Its MS^2^ spectrum produced the fragment ion at *m*/*z* 313, which involves the loss of H~2~O. The molecular ion yielded a series of fragment ions at *m*/*z* 287 \[M − H − CO~2~\]^−^, *m*/*z* 283 \[M − H − H~2~O − H~2~CO\]^−^ and *m*/*z* 271 \[M − H − CH~4~ − CO~2~\]^−^, suggesting the presence of -COOCH~3~. The base peak ion at *m*/*z* 285 was generated by losing water and carbon monoxide. The \[M − H − C~6~H~6~O\]^−^ ion at *m*/*z* 237 was generated by the fracture of C~9-11~ (C~6~H~6~O). Moreover, by comparison with the fragmentation patterns obtained from the two reference standards, compound **62** was tentatively identified as a new compound.

Compound **63** generated a \[M − H\]^−^ ion at *m*/*z* 363.21660 (C~21~H~31~O~5~). It generated a serial of fragment ions at *m*/*z* 345 \[M − H − H~2~O\]^−^, *m*/*z* 334 \[M − H − 29 amu\]^−^, *m*/*z* 317 \[M − H − H~2~O − CO\]^−^ and *m*/*z* 295 \[M − H − 2H~2~O − OCH~4~\]^−^. By comparison with the literature data, compound **63** was tentatively identified as tinotufolin C \[[@B21-molecules-22-00912]\].

2.3. Identification of Diterpenoids Glycosides {#sec2dot3-molecules-22-00912}
----------------------------------------------

Compounds **1** and **24** produced their \[M -- H\]^−^ ions at *m*/*z* 765.29642 (C~37~H~49~O~17~). After the CID cleavage, both of their further fragmentations resulted in a \[M − H − CO~2~\]^−^ ion at *m*/*z* 721 and a \[M − H − H~2~O − CO\]^−^ ion at *m*/*z* 719, which were consistent with the characteristic fragmentation pathways of diterpenoids. According to the fragmentation patterns and the values of Clog *P*, compounds **1** and **24** were plausibly characterized as (2,3,4,6)-2-(acetoxymethyl)-6-(((2,4,6,6,10,10)-2-(furan-3-yl)-9,10-dimethoxy-7-(methoxycarbonyl)-6,10-dimethyl-4-oxododecahydro-1*H*-benzo\[f\]isochromen-6-yl)-oxy)tetrahydro- 2*H*-pyran-3,4,5-triyl triacetate and rumphioside D, respectively.

Compounds **2**, **6** and **39** produced their \[M − H\]^−^ ions at *m*/*z* 537.19665 (C~26~H~33~O~12~). They all produced the \[M − H − H~2~O\]^−^ and \[M − H − H~2~O − CO\]^−^ ions at *m*/*z* 519 and *m*/*z* 491. In addition, compounds **2** and **39** also yielded the \[M − H − 162\]^−^ ions at *m*/*z* 375 due to the overall fracture of dehydrated glucose, which was the ESI-MS^2^ base peak of compound **2**. As well as we known, \[M − H − 162\]^−^ was the characteristic ion of glycosides. Furthermore, compounds **2**, **6** and **39** generated the ions at *m*/*z* 490 \[M − 2H − H~2~O − CO\]^−^, *m*/*z* 357 \[M − H − Glc\]^−^, *m*/*z* 327 \[M − H − Glc − 2CH~3~\]^−^, *m*/*z* 297 \[M − 2H − CO − Glc − OCH~3~\]^−^; *m*/*z* 492 \[M − 2H − CO~2~\]^−^, *m*/*z* 490 \[M − 2H − H~2~O − CO\]^−^, *m*/*z* 469 \[M − 2H − H~2~O − CO − OCH~3~\]^−^, *m*/*z* 297 \[M − 2H − CO − Glc − OCH~3~\]^−^; *m*/*z* 493 \[M − H − CO~2~\]^−^, *m*/*z* 357 \[M − H − Glc\]^−^, *m*/*z* 341 \[M − H − O − Glc\]^−^, *m*/*z* 329 \[M − H − CO − Glc\]^−^, *m*/*z* 297 \[M − 2H − CO − Glc −OCH~3~\]^−^, respectively. By comparison with the literature data, compounds **2**, **6** and **39** were tentatively assigned as cordioside, cordifoliside D and borapetoside A, respectively \[[@B22-molecules-22-00912],[@B23-molecules-22-00912]\].

Compounds **3**, **8**, **14**, **20**, **25**, **34**, **43**, **47** and **49** were all observed to possess the same \[M − H\]^−^ ions at *m*/*z* 597.21778 (C~28~H~37~O~14~). Firstly, they were divided into two categories based on whether they produced the \[M − H − 112\]^−^ ion at *m*/*z* 486 by the RDA cleavage from A-ring. Compound **47** generated its ESI-MS^2^ base peak ion at *m*/*z* 433 by losing dehydrated glucose. In addition, it also yielded \[M − H − 2H~2~O\]^−^ ion at *m*/*z* 561, \[M − H − H~2~O − CO\]^−^ ion at *m*/*z* 551, \[M − H − 112\]^−^ ion at *m*/*z* 486, \[M − H − dehydrated Glc\]^−^ ion at *m*/*z* 435, and so on. As far as we knew, there were no related literatures reported. And thus, compound **47** was finally deduced to be a new compound. Compounds **3**, **8**, **14**, **20**, **25**, **34**, **43** and **49** yielded their \[M − H − H~2~O − CO\]^−^ ions at *m*/*z* 551, which was the ESI-MS^2^ base peak of compounds **20** and **34**, and it also a high intense characteristic fragment ion of compound **49**. Compared with the prominent ions of them, there was no difficulty to deduce that compounds **34** and **49** have two lactone rings, which were different to the other compounds. Furthermore, the fragment ions further validated the above deduction. Finally, according to their Clog *P* values, they were tentatively identified and differentiated. By comparison with the bibliography and MS fragmentation data, compounds **3**, **8**, **14**, **20**, **25**, **34**, **43** and **49** were tentatively identified ([Table 1](#molecules-22-00912-t001){ref-type="table"}) \[[@B24-molecules-22-00912],[@B25-molecules-22-00912]\].

Compounds **4** and **46** generated their \[M − H\]^−^ ions at *m*/*z* 683.25456 (C~32~H~43~O~16~). Both of their deprotonated molecular ions yielded \[M − H − H~2~O\]^−^ ion at *m*/*z* 665, \[M − H − H~2~O − CO\]^−^ ion at *m*/*z* 637, \[M − H − C~4~H~4~O\]^−^ ion at *m*/*z* 615, \[M − H − dehydrated Glc\]^−^ ion at *m*/*z* 520, respectively. Moreover, compound **4** also dissociated into fragment ions \[M − H − CO2\]^−^ at *m*/*z* 639, \[M − H − Glc − dehydrated xyl\]^−^ at *m*/*z* 370 and \[M − H − Glc − dehydrated xyl − CO~2~ − H~2~O\]^−^ at *m*/*z* 309. According to the literature, compounds **4** and **46** were plausibly characterized as (2*R*,5*R*,6*R*,8*S*,9*S*,10*S*,12*S*)-15,16-epoxy-2-hydroxy-6-*O*-{β-[d]{.smallcaps}-xylopyranosyl(1→6)--[d]{.smallcaps}-glucopyranosyl}-cleroda-3,13(16),14-trien-17,12-olid-18-oic acid methyl ester and (2*R*,5*R*,6*R*,8*S*,9*S*,10*S*,12*S*)-15,16-epoxy-2-hydroxy-6-*O*-{β-[d]{.smallcaps}-glucopyranosyl-(1→6)-*α*-[d]{.smallcaps}-xylopyran-osyl}-cleroda-3,13(16),14-trien-17,12-olid-18-oic acid methyl ester, respectively \[[@B26-molecules-22-00912]\].

Compounds **5** and **18** produced their \[M − H\]^−^ ions at *m*/*z* 513.19665 (C~24~H~33~O~12~). The dominant characteristic fragment ions were presented at *m*/*z* 333 \[M -- H − 180\]^−^ and *m*/*z* 351 \[M − H − 162\]^−^ as the ESI-MS^2^ base peak corresponding to the cleavage from glucopyranosyl. After the CID cleavage, both of their further fragmentation resulted in \[M − H − H~2~O\]^−^ at *m*/*z* 495 and \[M − H − Glc − CO\]^−^ at *m*/*z* 305. The product ion at *m*/*z* 305 of compound **18** further generated the predominant ion at *m*/*z* 287 by losing one molecular of water. By comparison with the literature data and MS fragmentation data, compounds **5** and **18** were tentatively identified as 1-deacetyltinosposide A and (2*S*,6*R*,6a*R*,7*R*,9*S*,10*R*,10a*R*,10b*S*)-2-(furan-3-yl)-6,9,10--trihydroxy-10b-methyl-7-(((2*R*,3*R*,4*S*,5*S*,6*R*)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)decahydro-1*H*-benzo\[*f*\]isochromen-4(2*H*)-one, respectively \[[@B4-molecules-22-00912]\].

Compounds **7**, **10**, **15** and **17** gave their \[M − H\]^−^ ions at *m*/*z* 567.20721 (C~27~H~35~O~13~). They all produced the \[M − H − H~2~O − CO\]^−^ and \[M − H − Glc\]^−^ ions at *m*/*z* 521 and *m*/*z* 405. Besides, compounds **7** and **10** generated *m*/*z* 552 by losing a methyl, and the ion at *m*/*z* 341 was generated by losing a series of fragment ions of glucose residue, 2H~2~O, and CO. Compounds **7** and **15** were also generated \[M − H − Glc − CO\]^−^ ions at *m*/*z* 359, which was the ESI-MS^2^ base peak of compound **7**. Meanwhile, compound **7** generated the minor ion at *m*/*z* 329. Compound **17** produced its ESI-MS^2^ base peak by losing two molecular of methyl, one molecular of water and carbonyl at *m*/*z* 491. Combined with bibliography data and fragmentation pathways, these four compounds were tentatively deduced as tinospinoside D, amritoside C, rumphioside A and rumphioside F, respectively \[[@B25-molecules-22-00912]\].

Compounds **9**, **11**, **13**, **19**, **35** and **55** all produced their \[M − H\]^−^ ions at *m*/*z* 551.21230 (C~27~H~35~O~12~). Compounds **9**, **13** and **19** produced their ESI-MS^2^ base peak ions at *m*/*z* 389 \[M − H − dehydrated Glc\]^−^, and further generated a series of fragment ions by losing methyl, water, carbon dioxide units at the mean time. According to the literature and the values of Clog *P*, compounds **9**, **13** and **19** were plausibly characterized as borapetoside B, tinosposinenside A and (2*R*,5*R*,6*R*,8*R*,9*S*,10*S*,12*S*)-15,16-epoxy-2-hydroxy-6-*O*-(β-[d]{.smallcaps}-glucopyranosyl)-cleroda-3,13(16), 14-trien-17,12-olid-18-oic acid methyl ester, respectively \[[@B26-molecules-22-00912]\]. Compounds **11** and **55** generated their ESI-MS^2^ base peak ions at *m*/*z* 505 by losing water and carbonyl, and their deprotonated molecular ions loss of glucose residue at *m*/*z* 389. According to the fragmentation pathways and the values of Clog *P*, compounds **11** and **55** were tentatively identified as tinospinoside B and tinospinoside C, respectively. According to the above methods, compound **35** was tentatively defined as rumphioside I.

Compounds **12** and **21** yielded their \[M − H\]^−^ ions at *m*/*z* 535.18100 (C~26~H~31~O~12~). Compound **12** produced its ESI-MS^2^ base peak ion at *m*/*z* 373 by loss of a dehydrated glucose and then generated two minor ions at *m*/*z* 345 \[M − H − dehydrated Glc − CO\]^−^ and *m*/*z* 313 \[M − H − O − dehydrated Glc − CO~2~\]^−^. While compound **21** generated a series of fragment ions at *m*/*z* 520 \[M − H − CH~3~\]^−^, *m*/*z* 517 \[M − H − H~2~O\]^−^, *m*/*z* 373 \[M − H − dehydrated Glc\]^−^ and *m*/*z* 329 \[M − H − dehydrated Glc − CO~2~\]^−^. According to the fragmentation patterns and the values of Clog *P*, compounds **12** and **21** were tentatively characterized as (2,4,6,6,7,7,8,9,9,9)-2-(furan-3-yl)-6a,9b-dimethyl-6-(((2,3,4,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)decahydro-1*H*-9,7-(epoxymethano) oxireno\[2′,3′:4,5\]benzo\[1,2-f\]isochromene-4,11(2*H*)-dione and palmatoside F, respectively.

Compound **16** produced its \[M − H\]^−^ ion at *m*/*z* 521.20173 (C~26~H~33~O~11~). A high intense characteristic fragment ion was present at *m*/*z* 359 \[M -- H − 162\]^−^ as its ESI-MS^2^ base peak corresponding to the cleavage of the dehydrated glucose. The product ion at *m*/*z* 359 successively generated the predominant product ions at *m*/*z* 344 and *m*/*z* 341 by losing a methyl and one molecular of water. According to the literature data, compound **16** was tentatively identified as furanoid diterpene glycoside \[[@B27-molecules-22-00912]\].

Compound **22** generated its \[M − H\]^−^ ion at *m*/*z* 527.21230 (C~25~H~35~O~12~). Upon CID mode, its further fragmentation resulted in \[M − H − H~2~O\]^−^ ion at *m*/*z* 509, \[M − H − H~2~O − CH~3~\]^−^ ion at *m*/*z* 494, \[M -- H − H~2~O − CO\]^−^ ion at *m*/*z* 481, \[M − H − Glc\]^−^ ion at *m*/*z* 347, and \[M − H − Glc − CH~2~O − CO − CH~4~\]^−^ ion at *m*/*z* 273. As far as we knew, there were no related literatures reported. Thus, compound **22** was tentatively deduced to be a new compound.

Compounds **23**, **31** and **37** yielded their \[M − H\]^−^ ions at *m*/*z* 555.20721 (C~26~H~35~O~13~). Compound **31** produced its ESI-MS^2^ base peak ion at *m*/*z* 513 \[M − Ac\]^−^, and the *m*/*z* 513 ion generated its predominant ions at *m*/*z* 495 \[M − H − CH~2~CO − H~2~O\]^−^ and *m*/*z* 333 \[M − H − CH~2~CO − dehydrated Glc\]^−^ due to the overall fracture of a hydroxy and glycoside bond. The ion at *m*/*z* 333 generated two minor ions at *m*/*z* 315 and *m*/*z* 305 through losing H~2~O and CO, respectively. Besides, its \[M − H\]^−^ ion also yielded characteristic fragment ion at *m*/*z* 393 \[M − H − 162\]^−^ by losing a dehydrated glucose. By comparison with the literature data, compound **31** was tentatively identified as tinosineside A \[[@B24-molecules-22-00912]\]. Compounds **23** and **37** produced their fragment ions at *m*/*z* 537 \[M − H − H~2~O\]^−^, *m*/*z* 513 \[M − CH~3~ − CO\]^−^, *m*/*z* 495 \[M − H − CH~3~ − COOH\]^−^ and *m*/*z* 393 \[M − H − dehydrated Glc\]^−^. Furthermore, compound **23** generated the fragment ions at *m*/*z* 375 \[M − H--H~2~O--Glc\]^−^, *m*/*z* 305 \[M − H--dehydrated Glc--CH~4~ − CO − CO~2~\]^−^ and *m*/*z* 297 \[M − H − H~2~O − Glc − CO~2~ − CH~4~\]^−^ or \[M − H − 2H~2~O − Glc − CH~2~CO\]^−^. According to the fragment ions and the values of Clog *P*, compounds **23** and **37** were tentatively identified as amritoside A and (1,2,7,8)-1-(2-(furan-3-yl)-2-hydroxyethyl)-2-hydroxy-5-(methoxycarbonyl)-1-methyl-7-(((3,4,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)-1,2,3,4,6,7,8,8-octahydronaphthalene-2-carboxylic acid, respectively.

Compound **26** produced its \[M − H\]^−^ ion at *m*/*z* 523.21738 (C~26~H~35~O~11~). Its ESI-MS^2^ base peak ion at *m*/*z* 361 was yielded by loss of a dehydrated glucose. In addition, it generated a series fragment ions, such as *m*/*z* 508, *m*/*z* 505, *m*/*z* 347, *m*/*z* 343 and *m*/*z* 329, involving the loss of a methyl group, a water molecule, and glucose. By comparing with the fragmentation patterns obtained from two reference standards, compound **26** was tentatively identified as sagittatayunnanoside D. Similarly, based on the literature data, compound **27** was tentatively identified as borapetoside H \[[@B28-molecules-22-00912]\].

Compounds **28** and **33** exhibited their \[M − H\]^−^ ions at *m*/*z* 549.19665 (C~27~H~33~O~12~). Both of their deprotonated molecular ions generated a serial of fragment ions at *m*/*z* 531 \[M − H − H~2~O\]^−^, *m*/*z* 503 \[M − H − H~2~O − CO\]^−^, *m*/*z* 481 \[M − H − 2H~2~O − CH~3~OH\]^−^ and *m*/*z* 387 \[M − H − dehydrated Glc\]^−^, respectively. Meanwhile, a product ion at *m*/*z* 513 \[M − H − 2H~2~O\]^−^ was observed in the ESI-MS/MS spectra of compound **33**, suggesting there was two hydroxy groups at the skeleton. According to the literature data and the values of Clog *P*, compounds **28** and **33** were tentatively identified as (5*R*,6*R*,8*S*,9*R*,10*R*,12*S*)-15,16-epoxy-2-oxo-6-*O*-(β-[d]{.smallcaps}-glucopyranosyl)--cleroda-3,13(16),14-trien-17,12 -olid-18-oic acid methyl ester and tinoscorside C, respectively \[[@B26-molecules-22-00912]\].

Compound **30** generated its \[M − H\]^−^ ion at *m*/*z* 519.18608 (C~26~H~31~O~11~). The dominant characteristic fragment ion was present at *m*/*z* 357 \[M − H − 162\]^−^ as its ESI-MS^2^ base peak, corresponding to the cleavage from the dehydrated glucose. Meanwhile, the product ions \[M − H − H~2~O\]^−^ (lose of water) at *m*/*z* 501 and \[M − H − 46\]^−^ (lose of water and carbon monoxide) at *m*/*z* 473 were monitored, which were in accordance with the diterpenoids glycosides cracking patterns, suggesting this compound might be tinoside.

Compounds **36** and **44** yielded their \[M − H\]^−^ ions at *m*/*z* 535.21738 (C~27~H~35~O~11~). Both of their deprotonated molecular ions generated a serial of fragment ions at *m*/*z* 520 \[M − H − CH~3~\]^−^, *m*/*z* 488 \[M − 2H − CO − H~2~O\]^−^, *m*/*z* 373 \[M − H − dehydrated Glc\]^−^, *m*/*z* 359 \[M − H − dehydrated Glc − CH~2~\]^−^, *m*/*z* 358 \[M − H − dehydrated Glc − CH~3~\]^−^, *m*/*z* 355 \[M − H − Glc\]^−^ and *m*/*z* 341 \[M − H − Glc − CH~2~\]^−^. According to the literature data and the values of Clog *P*, compounds **36** and **44** were tentatively identified as borapetoside C and tinocrisposide \[[@B29-molecules-22-00912]\].

Compound **38** gave a \[M − H\]^−^ ion at *m*/*z* 581.22286 (C~28~H~37~O~13~). Its major ions in the MS^2^ spectrum were *m*/*z* 563 \[M − H − H~2~O\]^−^, *m*/*z* 535 \[M − H − H~2~O − CO\]^−^, *m*/*z* 419 \[M − H − dehydrated Glc\]^−^, *m*/*z* 373 \[M − H − Glc − CO\]^−^ and *m*/*z* 343 \[M − Glc − CH~2~CO~2~\]^−^, suggesting this compound might contain the glucose and acetyl fragments. Comparison with the parent nucleus and fragmentation patterns, compound **38** was tentatively identified as tinosposinenside B.

Compound **42** exhibited its \[M − H\]^−^ ion at *m*/*z* 537.23303 (C~27~H~37~O~11~). Its ESI-MS^2^ base peak ion at *m*/*z* 375 was produced by losing dehydrated glucose, and the product ion at *m*/*z* 375 further generated two minor ions at *m*/*z* 360 and *m*/*z* 357 by losing CH~3~ and H2O, respectively. According to the fragmentation pathways, compound **42** was tentatively identified as boropetoside G. Likewise, compound **48** was tentatively defined as tinosposinenside C.

Compound **45** produced its \[M − H\]^−^ ion at *m*/*z* 597.20002 (C~28~H~37~O~12~S), which exhibited the characteristic fragment ion \[M − H − C~8~H~14~O~6~S\]^−^ at *m*/*z* 359 suggesting the overall fracture of side chain. S-diterpenoids glycosides were very rare in *Tinospora*, and there only two compounds were reported in this family so far \[[@B30-molecules-22-00912]\]. By comparison with the fragmentation pathways, compound **45** was plausibly described as cordifolide A.

Compounds **50** and **59** produced their \[M − H\]^−^ ions at *m*/*z* 623.23343 (C~30~H~39~O~14~). According to the respective fragmentation pathways and the values of Clog *P*, compounds **50** and **59** were tentatively identified as 6′-*O*-lactoylborapetoside B and 2-*O*-lactoylborapetoside B, respectively.

Compounds **52**--**54** produced their respective \[M − H\]^−^ ion at *m*/*z* 517.17043 (C~26~H~29~O~11~), *m*/*z* 491.19117 (C~25~H~31~O~10~) and *m*/*z* 715.28077 (C~33~H~47~O~17~). None but compound **53** exhibited the \[M − H + HCOOH\]^−^ adduct ion at *m*/*z* 537.19665 (C~26~H~33~O~12~). Take compound **52** for example, its major ions in ESI-MS^2^ spectrum were *m*/*z* 499 \[M − H − H~2~O\]^−^, *m*/*z* 473 \[M − H − CO~2~\]^−^, *m*/*z* 471 \[M − H − H~2~O − CO\]^−^, *m*/*z* 455 \[M − H − CO~2~ − H~2~O\]^−^, *m*/*z* 355 \[M − H − dehydrated Glc\]^−^, *m*/*z* 162 −C~6~H~10~O~5~ and *m*/*z* 151 --C~5~H~11~O~5~, suggesting this compound might contain glucose and undergo a RDA coverage from the A-ring at the 1,4-position. According to the above analysis, compounds **52**--**54** were tentatively defined as tinospinoside E, tinosporaside and sagittatayunnanoside B, respectively.

Compounds **56** and **58** generated their respective \[M − H\]^−^ ion at *m*/*z* 671.29094 (C~32~H~47~O~15~) and 509.23812 (C~26~H~37~O~10~). The defference between of these molecules was 162 Da, suggesting that compound **56** had one more glucose unit than compound **58**. Both of them generated the same ESI-MS^2^ base peak ions at *m*/*z* 329 due to the overall fracture of glycoside bond. Furthermore, the product ion at *m*/*z* 329 generated a predominant ion at *m*/*z* 301 by splitting off CO. Comparing with the parent nucleus and respective fragmentation pathways, compounds **56** and **58** were plausibly identified as sagittatayunnanoside C and sagittatayunnanoside A, respectively.

2.4. Target Isolation and Further Verification of Diterpenoids Fragmentation Patterns {#sec2dot4-molecules-22-00912}
-------------------------------------------------------------------------------------

Tinosineside A generated its deprotonated molecular ion \[M − H\]^−^ at *m*/*z* 555.20721 (C~26~H~35~O~13~, mass error within 3 ppm). It firstly produced the ESI-MS^2^ base peak ion at *m*/*z* 513 \[M − Ac\]^−^ and further generated the ions at *m*/*z* 495 and *m*/*z* 375 by losing one molecule of water and dehydrated glucose. The ion at *m*/*z* 351 generated minor ions at *m*/*z* 333, *m*/*z* 315 and *m*/*z* 307 through losing H~2~O, 2H~2~O and CO2, respectively. Besides, its \[M − H\]^−^ ion also yielded characteristic fragment ion at *m*/*z* 393 \[M − H − 162\]^−^ by losing a dehydrated glucose. The fragmentation pathway was consistent with deduced of compound 31, which further proved the validity of the results ([Figure 3](#molecules-22-00912-f003){ref-type="fig"}).

3. Materials and Methods {#sec3-molecules-22-00912}
========================

3.1. Chemicals {#sec3dot1-molecules-22-00912}
--------------

The reference standards of columbin and isocolumbin (purity over 98%) were procured from Tauto Biotech (Shanghai, China).The structures of these standards were presented in [Figure 1](#molecules-22-00912-f001){ref-type="fig"}. HPLC grade formic acid, acetonitrile and methanol were purchased from Fisher Scientific (Fair Lawn, NJ, USA). Ultrapure water was purchased from Hangzhou Wahaha Group Co., Ltd. (Hangzhou, Zhejiang, China). Material of *T. sinensis* was purchased from Anguo Linshi Medicinal Materials Co., Ltd. (Anguo, China) and then authenticated by Professor Chun-sheng Liu in Beijing University of Chinese Medicine.

3.2. Sample Preparation {#sec3dot2-molecules-22-00912}
-----------------------

### 3.2.1. Standard Solutions {#sec3dot2dot1-molecules-22-00912}

The standard solutions of columbin and isocolumbin were prepared in methanol at appropriate concentrations.

### 3.2.2. Sample Solutions {#sec3dot2dot2-molecules-22-00912}

Powdered dried alcoholic extracts of *T. sinensis* were weighed accurately (0.13 g) and refluxed with a tenfold excess of ethanol/water (70:30, *v*/*v*) three times, and placed in 20 mL of methanol/water (70:30, *v*/*v*). The mixture was then extracted in an ultrasonic bath at room temperature for 0.5 h, and the same solvent was added to compensate for the weight lost during the extraction. The extract was filtered and evaporated to near dryness, then placed on a C~18~ Solid Phase Extraction (SPE) column (J.T.Baker, Phillipsburg, NJ, USA), which was washed with 4 mL distilled water and 4 mL methanol. The methanol eluent was filtered through a 0.22 µm membrane for analysis. All of the solutions were stored at 4 °C and brought to room temperature before analysis.

3.3. Instrumentation and Condition {#sec3dot3-molecules-22-00912}
----------------------------------

HPLC analysis was carried out on a DIONEX Ultimate 3000 UHPLC system (Thermo Fisher Scientific, Waltham, MA, USA) with a binary pump and an autosampler. The samples were separated on a Sunfire C18 column (250 mm × 4.6 mm i.d., 5 μm, Waters Corporation, Milford, MA, USA) at room temperature. The mobile phase consisted of acetonitrile (**B**) and 0.1% (*v*/*v*) formic acid in water (**A**) with the elution gradient set as follows: 0--5 min, 8--12% **B**; 5--25 min, 12--16% **B**, 25--45 min, 16--25% **B**; 45--75 min, 25--46% **B**; 75--80 min, 46--58% **B**; 80--95 min, 58--65% **B**; 95--105 min. The flow rate was set as 1.0 mL/min.

A LTQ-Orbitrap XL mass spectrometer (Thermo Scientific, Bremen, Germany) was connected to the HPLC system via an electrospray ionization (ESI) interface. The effluent was introduced into the ESI source in a post-column splitting ratio of 1:4. Full scan data acquisition was performed from *m*/*z* 100 to 1500 in negative ion mode. The important ESI parameters were set as follows: capillary temperature, 350 °C; sheath gas (nitrogen) flow, 30 arb.; auxiliary gas (nitrogen) flow, 10 arb.; electrospray voltage, 3.0 kV; capillary voltage, −35 V; tube lens voltage, −110 V. The resolution of Orbitrap analyzer was set at 30,000 with data-dependent ESI-MS^2^ analysis triggered by the three most abundant ions from one-stage mass spectrometry scanning. Collision-induced dissociation (CID) was performed in LTQ with an activation *q* of 0.25 and activation time of 30 ms. The isolation width was 2 amu, and the normalized collision energy was set to 35%.

3.4. Peak Selections and Data Processing {#sec3dot4-molecules-22-00912}
----------------------------------------

A Thermo Xcalibur 2.1 workstation was used for the data acquisition and processing, In order to obtain as many fragment ions of the diterpenoids as possible, the peaks detected with intensity over 30,000 were selected for identification. The chemical formulas for all parent ions of the selected peaks were calculated from the accurate mass using a formula predictor by setting the parameters as follows: C (0--50), H (0--100), O (0--30), S (0--2), N (0--2). Other elements were not considered because they are rarely present in diterpenoids. Furthermore, diterpenoids isomers were differentiated by an important Clog *P* parameter obtained from Chemdraw to distinguish their polarity. And the exact mass error of all determined compounds was within 3 ppm.

3.5. Extraction and Isolation of Tinosineside A {#sec3dot5-molecules-22-00912}
-----------------------------------------------

The air-dried stems (10.0 kg) were extracted three times with tenfold excess of 70% EtOH under reflux for 2 h each at 80 °C. The combined extract was evaporated under reduced pressure to obtain a crude residue. This residue was further dispersed in H~2~O, and then successively extracted with CHCl~3~, EtOAc, *n*-BuOH and MeOH. The *n*-BuOH extract was passed through an AB-8 macroporous resin column and then washed with H~2~O, 30% EtOH, 50% EtOH, 70% EtOH and 95% EtOH. The 30% EtOH fraction was further purified by silica gel column chromatography with elution by CHCl~3~--MeOH (15:1→4:1, *v*/*v*) to give the diterpenoid glycoside named tinosineside A as a white powder.

4. Conclusions {#sec4-molecules-22-00912}
==============

In this study, a sensitive HPLC-LTQ-Orbitrap coupled with EIC data-mining method was established for the rapid characterization of diterpenoids in *T. sinensis*. According to the characteristic fragmentation pathways of two reference standards, all diterpenoids were divided into two categories, namely diterpenoid aglycones and diterpenoid glycosides. Furthermore, an important parameter Clog *P* was used to differentiate the isomers of diterpenoids. As a result, 63 diterpenoids were preliminarily identified, including 48 known compounds and 15 new compounds. These compounds included 10 diterpenoid aglycones, 53 diterpenoid glycosides. Finally, target isolation of one diterpenoid glycoside named tinosineside A was performed based on the obtained results, which further confirmed the deduced fragmentation patterns and identified profile of diterpenoids in *T. sinensis*. This represents the first systematic report of diterpenoids in *T. sinensis*. The results indicated that the established method could be employed as a rapid, effective technique to screen and identify diterpenoids in *T. sinensis*. The study also provided significant guidance for the analysis of other herbal medicines or preparations.
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![Proposed MS/MS mechanistic pathways for columbin and isocolumbin.](molecules-22-00912-g001){#molecules-22-00912-f001}

![TIC chromatogram of *T. sinensis* in negative ion mode.](molecules-22-00912-g002){#molecules-22-00912-f002}

###### 

Spectra of ion fragments in MS^n^ analysis of tinosineside A in negative ion mode.
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###### 

Summary of chemical constituents identified in *Tinospora sinensis* by HPLC-LTQ-Orbitrap.

  NO.               t~R~/min               Identification                                                                                                                                                                                                                                             Empirical Formula   Proposed Ions   Experimental Mass *m*/z                                      Theoretical Mass *m*/*z*   Mass Error (×10^−6^)   MS^2^ Data (Measured)
  ----------------- ---------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------- --------------- ------------------------------------------------------------ -------------------------- ---------------------- -------------------------------------------------------------------------------------------
  **1**             16.13                  (2,3,4,6)-2-(Acetoxymethyl)-6-(((2,4,6,6,10,10)-2-(furan-3-yl)-9,10-dimethoxy-7-(methoxycarbonyl)-6,10-dimethyl-4-oxododecahydro-1*H*-benzo\[f\]isochromen-6-yl)oxy)-tetrahydro-2*H*-pyran-3,4,5-triyl triacetate \*                                       C~37~H~49~O~17~     \[M − H\]^−^    765.29578                                                    765.29642                  0.836                  747(10), 737(48), 721(38), 720(43), 719(100), 697(5), 672(11), 555(18)
  **2**             17.69                  Cordioside                                                                                                                                                                                                                                                 C~26~H~33~O~12~     \[M − H\]^−^    537.19592                                                    537.19665                  1.359                  519(4), 491(8), 490(13), 375(100), 357(43), 327(88), 297(4)
  **3**             18.55                  (4,6,6,7,9,10,10,10)-2-(Furan-3-yl)-7-hydroxy-10b-methyl-4-oxo-6-(((3,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2*H*-pyran-2-yl)-oxy)dodecahydro-1*H*-benzo-\[f\]isochromene-9,10-diyl diacetate \*                                               C~28~H~37~O~14~     \[M − H\]^−^    597.21661                                                    597.21778                  1.959                  579(3), 551(60), 476(7), 435(10), 389(96), 359(100)
  **4**             20.51                  (2,5,6,8,9,10,12)-15,16-Epoxy-2-hydroxy-6-*O*-{β-[d]{.smallcaps}-xylopyranosyl(1→6)-[d]{.smallcaps}-glucopyranosyl}-cleroda-3,13(16),14-trien-17,12-olid-18-oic acid methyl ester \*                                                                       C~32~H~43~O~16~     \[M − H\]^−^    683.25372                                                    683.25456                  1.229                  665(68), 639(12), 637(16), 615(95), 520(100), 519(79), 370(15), 309(37)
  **5**             21.89                  1-Deacetyltinosposide A                                                                                                                                                                                                                                    C~24~H~33~O~12~     \[M − H\]^−^    513.19678                                                    513.19665                  −0.253                 495(3), 351(12), 333(100), 307(11), 305(5), 271(5)
  **6**             25.01                  Cordifoliside D                                                                                                                                                                                                                                            C~26~H~33~O~12~     \[M − H\]^−^    537.19623                                                    537.19665                  0.782                  519(38), 492(22), 491(100), 490(71), 469(71), 297(38)
  **7**             26.40                  Tinospinoside D                                                                                                                                                                                                                                            C~27~H~35~O~13~     \[M − H\]^−^    567.20660                                                    567.20721                  1.075                  552(1), 521(9), 404(0.5), 359(100), 341(2), 329(2)
  **8**             26.55                  (6,6,10,10,10)-Methyl 10-acetoxy-2-(furan-3-yl)-9-hydroxy-10b-methyl-4-oxo-6-(((3,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)-dodecahydro-1*H*-benzo\[f\]-isochromene-7-carboxylate \*                                          C~28~H~37~O~14~     \[M − H\]^−^    597.21741                                                    597.21778                  0.619                  565(4), 551(21), 550(25), 535(10), 463(12), 435(12), 389(100), 388(12)
  **9**             26.98                  Borapetoside B                                                                                                                                                                                                                                             C~27~H~35~O~12~     \[M − H\]^−^    551.21204                                                    551.21230                  0.471                  536(5), 533(2), 507(3), 389(100), 388(15), 371(2), 370(7), 329(2)
  **10**            27.65                  Amritoside C                                                                                                                                                                                                                                               C~27~H~35~O~13~     \[M − H\]^−^    567.20612                                                    567.20721                  1.921                  552(6), 529(20), 521(100), 404(10), 341(4)
  **11**            29.43                  Tinospinoside B                                                                                                                                                                                                                                            C~27~H~35~O~12~     \[M − H\]^−^    551.21298                                                    551.21230                  −1.233                 533(9), 532(31), 515(12), 505(100), 389(8), 344(8)
  **12**            29.52                  (2,4,6,6,7,7,8,9,9,9)-2-(furan-3-yl)-6a,9b-dimethyl-6-(((2,3,4,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2*H*-pyran-2-yl)oxy)decahydro-1*H*-9,7-(epoxymethano)-oxireno\[2′,3′:4,5\]benzo\[1,2-f\]isochromene-4,11(2*H*)-dione \*                  C~26~H~31~O~12~     \[M − H\]^−^    535.18036                                                    535.18100                  1.196                  517(0.5), 489(2), 467(2), 373(100), 345(1), 343(2), 313(2)
  **13**            30.82                  Tinosposinenside A                                                                                                                                                                                                                                         C~27~H~35~O~12~     \[M − H\]^−^    551.21173                                                    551.21230                  1.034                  536(5), 533(3), 507(3), 389(100), 374(11), 371(16), 359(2), 341(7)
  **14**            31.03                  (6,6,7,9,10,10,10)-2-(Furan-3-yl)-7-hydroxy-10b-methyl-4-oxo-6-(((3,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2*H*-pyran-2-yl)oxy)dodecahydro-1*H*-benzo-\[f\]isochromene-9,10-diyl diacetate \*                                                  C~28~H~37~O~14~     \[M − H\]^−^    597.21692                                                    597.21778                  1.440                  579(4), 561(11), 551(13), 529(19), 515(5), 477(6), 435(12), 389(82), 359(100)
  **15**            31.41                  Rumphioside A                                                                                                                                                                                                                                              C~27~H~35~O~13~     \[M − H\]^−^    567.20685                                                    567.20721                  0.635                  549(14), 548(25), 535(25), 521(34), 405(46), 404(100), 359(56)
  **16**            31.97                  Furanoid diterpene glycoside                                                                                                                                                                                                                               C~26~H~33~O~11~     \[M − H\]^−^    521.20099                                                    521.20173                  1.420                  506(1), 359(100), 345(3), 344(4), 341(3)
  **17**            32.03                  Rumphioside F                                                                                                                                                                                                                                              C~27~H~35~O~13~     \[M − H\]^−^    567.20642                                                    567.20721                  1.393                  549(22), 521(47), 491(100), 405(11), 404(18), 387(19)
  **18**            33.06                  (2,6,6,7,9,10,10,10)-2-(Furan-3-yl)-6,9,10-trihydroxy-10b-methyl-7-(((2,3,4,5,6)-3,4,5-trihydroxy-6-(hydroxyl-methyl)tetrahydro-2*H*-pyran-2-yl)oxy)decahydro-1*H*-benzo\[*f*\]isochromen-4(2*H*)-one \*                                                   C~24~H~33~O~12~     \[M − H\]^−^    513.19635                                                    513.19665                  0.585                  495(3), 467(1), 351(100), 305(60), 287(7), 161(3)
  **19**            34.12                  (2*R*,5*R*,6*R*,8*R*,9*S*,10*S*,12*S*)-15,16-Epoxy-2-hydroxy-6-*O*-(β-[d]{.smallcaps}-glucopyranosyl)-cleroda-3,13(16),14-trien-17,12-olid-18-oic acid methyl ester                                                                                        C~27~H~35~O~12~     \[M − H\]^−^    551.21185                                                    551.21230                  0.816                  533(2), 519(3), 505(4), 482(4), 389(100), 327(67)
  **20**            35.07                  Tinosineside B                                                                                                                                                                                                                                             C~28~H~37~O~14~     \[M − H\]^−^    597.21716                                                    597.21778                  1.038                  578(20), 551(100), 529(10), 517(12), 461(25), 179(49)
  **21**            35.26                  Palmatoside F                                                                                                                                                                                                                                              C~26~H~31~O~12~     \[M − H\]^−^    535.17987                                                    535.18100                  2.111                  520(4), 517(2), 488(3), 373(93), 329(100)
  **22**            35.35                  (2,6,7,9,10,10,10)-2-(Furan-3-yl)-7,10-dihydroxy-9-methoxy-10b-methyl-6-(((2,3,4,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)deca-hydro-1*H*-benzo\[*f*\]isochromen-4(2*H*)-one \*                                               C~25~H~35~O~12~     \[M − H\]^−^    527.21241                                                    527.21230                  −0.209                 511(14), 509(3), 494(14), 481(100), 347(6), 300(7)
  **23**            35.80                  Amritoside A                                                                                                                                                                                                                                               C~26~H~35~O~13~     \[M − H\]^−^    555.20624                                                    555.20721                  1.747                  537(5), 513(34), 495(53), 467(19), 393(100), 375(5), 305(74), 287(7)
  **24**            36.87                  Rumphioside D                                                                                                                                                                                                                                              C~37~H~49~O~17~     \[M − H\]^−^    765.29431                                                    765.29642                  2.757                  747(19), 734(20), 721(37), 719(41), 718(100), 697(18), 600(26), 418(4), 393(11)
  **25**            38.12                  (4,6,6,9,10,10)-Methyl 9-acetoxy-2-(furan-3-yl)-4a- hydroxy-10b-methyl-4-oxo-6-(((3,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)-dodecahydro-1*H*-benzo\[f\]isochromene-7-carboxylate \*                                         C~28~H~37~O~14~     \[M − H\]^−^    597.21619                                                    597.21778                  2.662                  582(73), 579(9), 556(41), 551(28), 550(72), 434(31), 416(33), 389(75), 329(100)
  **26**            38.15                  Sagittatayunnanoside D                                                                                                                                                                                                                                     C~26~H~35~O~11~     \[M − H\]^−^    523.21667                                                    523.21738                  1.357                  508(1), 505(1), 361(100), 347(8), 343(4), 329(4)
  **27**            38.26                  Borapetoside H                                                                                                                                                                                                                                             C~33~H~45~O~17~     \[M − H\]^−^    713.26588                                                    713.26512                  −1.066                 694(12), 668(18), 667(29), 666(100), 645(23), 551(21), 533(6), 389(6)
  **28**            38.38                  (5*R*,6*R*,8*S*,9*R*,10*R*,12*S*)-15,16-Epoxy-2-oxo-6-*O*-(β-[d]{.smallcaps}-glucopyranosyl)--cleroda-3,13(16) 14-trien-17,12-olid-18-oic acid methyl ester                                                                                                C~27~H~33~O~12~     \[M − H\]^−^    549.19592                                                    549.19665                  1.329                  531(0.4), 503(5), 481(3), 387(100), 249(1)
  **29**            38.80                  Isocolumbin ^a^                                                                                                                                                                                                                                            C~20~H~21~O~6~      \[M − H\]^−^    357.13321                                                    357.13326                  0.140                  342(9), 339(2), 313(1), 311(13), 151(100), 135(37)
  **30**            38.84                  Tinoside                                                                                                                                                                                                                                                   C~26~H~31~O~11~     \[M − H\]^−^    519.18542                                                    519.18608                  1.271                  501(0.1), 473(0.3), 358(0.4), 357(100)
  **31**            39.44                  Tinosineside A                                                                                                                                                                                                                                             C~26~H~35~O~13~     \[M − H\]^−^    555.20581                                                    555.20721                  2.522                  513(100), 495(69), 393(2), 375(8), 333(28), 315(10), 307(13), 305(1)
  **32**            40.03                  Tinocapilactone B                                                                                                                                                                                                                                          C~22~H~25~O~8~      \[M − H\]^−^    417.15411                                                    417.15439                  0.671                  402(42), 371(9), 356(2), 181(100), 166(34), 151(16)
  **33**            40.61                  Tinoscorside C                                                                                                                                                                                                                                             C~27~H~33~O~12~     \[M − H\]^−^    549.19586                                                    549.19665                  1.438                  531(7), 513(2), 503(13), 481(10), 417(5), 387(100)
  **34**            40.79                  (1,3,10,10)-9-(2-Methoxy-2,5-dihydrofuran-3-yl)-10a-methyl-4,7-dioxo-3-(((2,3,4,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)tetra-decahydroisobenzofuro\[7,1-fg\]isochromen-1-yl acetate \*                                      C~28~H~37~O~14~     \[M − H\]^−^    597.21655                                                    597.21778                  2.060                  579(51), 551(100), 528(39), 471(12)
  **35**            41.60                  Rumphioside I                                                                                                                                                                                                                                              C~27~H~35~O~12~     \[M − H\]^−^    551.21210                                                    551.21230                  0.363                  533(9), 519(11), 505(2), 482(3), 339(100), 324(5)
  **36**            42.17                  Borapetoside C                                                                                                                                                                                                                                             C~27~H~35~O~11~     \[M − H\]^−^    535.21637                                                    535.21738                  1.887                  520(1), 517(4), 488(1), 373(100), 359(5), 358(7), 355(2), 341(5)
  **37**            43.22                  (1,2,7,8)-1-(2-Ffuran-3-yl)-2-hydroxyethyl)-2-hydroxy-5-(methoxycarbonyl)-1-methyl-7-(((3,4,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)-1,2,3,4,6,7,8,8-octahydronaphthalene-2-carboxylic acid \*                                 C~26~H~35~O~13~     \[M − H\]^−^    555.20630                                                    555.20721                  1.639                  537(0.2), 513(1), 495(100), 393(0.2), 333(1), 297(2), 178(0.2)
  **38**            43.99                  Tinosposinenside B                                                                                                                                                                                                                                         C~28~H~37~O~13~     \[M − H\]^−^    581.22162                                                    581.22286                  2.133                  563(8), 535(37), 419(2), 373(33), 343(100), 297(6)
  **39**            44.59                  Borapetoside A                                                                                                                                                                                                                                             C~26~H~33~O~12~     \[M − H\]^−^    537.19604                                                    537.19665                  1.136                  519(4), 493(2), 491(62), 375(3), 371(5), 357(1), 341(2), 329(100), 297(1)
  **40**            45.22                  8-Hydroxycolumbin                                                                                                                                                                                                                                          C~20~H~21~O~7~      \[M − H\]^−^    373.12759                                                    373.12817                  1.554                  358(2), 343(45), 325(6), 313(100)
  **41**            45.78                  6-Hydroxycolumbin                                                                                                                                                                                                                                          C~20~H~21~O~7~      \[M − H\]^−^    373.12759                                                    373.12817                  1.554                  358(9), 355(7), 343(79), 329(3), 325(15), 313(100), 305(3), 261(2)
  **42**            46.04                  Boropetoside G                                                                                                                                                                                                                                             C~27~H~37~O~11~     \[M − H\]^−^    537.23218                                                    537.23303                  1.582                  518(1), 375(100), 361(9), 360(2), 357(2), 343(2)
  **43**            46.82                  (4,6,6,9,10,10)-Methyl 9-acetoxy-2-(furan-3-yl)-4a-hydroxy-10b-methyl-4-oxo-6-(((3,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)dodec-ahydro-1*H*-benzo\[f\]isochromene-7-carboxylate \*                                          C~28~H~37~O~14~     \[M − H\]^−^    597.2168                                                     597.21778                  1.641                  579(23), 565(52), 564(45), 551(27), 529(31), 389(10), 329(100)
  **44**            46.89                  Tinocrisposide                                                                                                                                                                                                                                             C~27~H~35~O~11~     \[M − H\]^−^    535.21600                                                    535.21738                  2.578                  520(2), 516(5), 488(7), 373(100), 359(8), 358(6), 355(3), 341(2)
  **45**            49.44                  Cordifolide A                                                                                                                                                                                                                                              C~28~H~37~O~12~S    \[M − H\]^−^    597.19922                                                    597.20002                  1.340                  579(13), 553(33), 550(53), 533(100), 528(25), 467(43), 466(25), 434(18), 372(32), 359(11)
  **46**            49.89                  (2*R*,5*R*,6*R*,8*S*,9*S*,10*S*,12*S*)-15,16-Epoxy-2-hydroxy-6-*O*-{β-[d]{.smallcaps}-glucopyranosyl-(1→6)-*α*-[d]{.smallcaps}-xylopyranosyl}-cleroda-3,13(16),14-trien-17,12-olid-18-oic acid methyl ester                                                C~32~H~43~O~16~     \[M − H\]^−^    683.25416                                                    683.25456                  0.585                  665(2), 664(11), 637(2), 615(3), 534(3), 520(100), 502(93), 490(12)
  **47**            50.40                  3-((6,6,7,10,10,10)-7-Hydroxy-6a,10b-dimethyl-4,12-dioxo-6-(((3,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)oxy)-2,4,4,5,6,6,7,10,10,10-decahydro-1*H*-10,7-(epoxymethano)benzo\[f\]isochromen-2-yl)tetrahydrofuran-2-yl acetate \*   C~28~H~37~O~14~     \[M − H\]^−^    597.21680                                                    597.21778                  1.641                  579(1), 561(15), 551(9), 495(6), 487(7), 486(66), 435(4), 433(100), 297(44)
  **48**            51.12                  Tinosposinenside C                                                                                                                                                                                                                                         C~26~H~35~O~12~     \[M − H\]^−^    539.21155                                                    539.21230                  1.391                  521(3), 497(100), 479(86), 478(8), 377(2)
  **49**            52.20                  (1,3,10,10)-9-(2-Methoxy-2,5-dihydrofuran-3-yl)-10a-methyl-4,7-dioxo-3a-(((2,3,4,5,6)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2*H*-pyran-2-yl)oxy)tetra-decahydroisobenzofuro\[7,1-fg\]isochromen-1-yl acetate \*                                     C~28~H~37~O~14~     \[M − H\]^−^    597.21655                                                    597.21778                  2.060                  579(0.4), 551(98), 509(7), 491(100), 481(6), 435(2)
  **50**            59.05                  6′-*O*-Lactoylborapetoside B                                                                                                                                                                                                                               C~30~H~39~O~14~     \[M − H\]^−^    623.23434                                                    623.23343                  −1.460                 513(3), 460(100), 458(7), 446(7), 444(4), 297(1), 283(12)
  **51**            59.98                  Columbin ^a^                                                                                                                                                                                                                                               C~20~H~21~O~6~      \[M − H\]^−^    357.13297                                                    357.13326                  0.812                  
  **52**            60.37                  Tinospinoside E                                                                                                                                                                                                                                            C~26~H~29~O~11~     \[M − H\]^−^    517.16986                                                    517.17043                  1.102                  499(26), 473(10), 471(20), 381(13), 355(6), 341(11), 162(100), 151(6)
  **53**            61.73                  Tinosporaside                                                                                                                                                                                                                                              C~25~H~31~O~10~     \[M − H\]^−^    491.19087                                                    491.19117                  0.611                  473(28), 472(100), 460(8), 444(0.3), 327(0.4), 312(2)
  C~26~H~33~O~12~   \[M − H + HCOOH\]^−^   537.19697                                                                                                                                                                                                                                                  537.19665           −0.596          519(4), 518(11), 491(25), 490(100), 357(3), 343(4), 327(8)                                                     
  **54**            62.14                  Sagittatayunnanoside B                                                                                                                                                                                                                                     C~33~H~47~O~17~     \[M − H\]^−^    715.28030                                                    715.28077                  0.657                  670(2), 628(1), 652(1), 552(100), 551(16)
  **55**            63.08                  Tinospinoside C                                                                                                                                                                                                                                            C~27~H~35~O~12~     \[M − H\]^−^    551.21155                                                    551.21230                  1.361                  533(73), 507(90), 505(100), 483(85), 415(84), 389(22), 343(81)
  **56**            63.14                  Sagittatayunnanoside C                                                                                                                                                                                                                                     C~32~H~47~O~15~     \[M − H\]^−^    671.28912                                                    671.29094                  2.711                  653(1), 627(2), 509(50), 347(27), 329(100), 301(70), 241(25)
  **57**            63.83                  Tinosponone                                                                                                                                                                                                                                                C~19~H~21~O~5~      \[M − H\]^−^    329.13791                                                    329.13835                  1.337                  314(100), 311(24), 285(70), 191(18)
  **58**            65.99                  Sagittatayunnanoside A                                                                                                                                                                                                                                     C~26~H~37~O~10~     \[M − H\]^−^    509.23792                                                    509.23812                  0.393                  491(5), 465(5), 347(33), 329(100), 301(89), 257(9), 241(11)
  **59**            69.79                  2-*O*-Lactoylborapetoside B                                                                                                                                                                                                                                C~30~H~39~O~14~     \[M − H\]^−^    623.23334                                                    623.23343                  0.144                  608(1), 591(23), 551(7), 486(16), 460(100), 297(34)
  **60**            78.98                  Tinotufolin D                                                                                                                                                                                                                                              C~20~H~25~O~4~      \[M − H\]^−^    329.17441                                                    329.17473                  0.972                  311(36), 285(100), 293(7), 267(10), 249(16)
  **61**            82.48                  (2aβ,3*α*,5aβ,6β,7*α*,8a*α*)-6-2-(3-Furanyl)ethyl-2a,3,4,5,5a,6,7,8,8a,8b-decahydro-2a,3-dihydroxy-6,7,8b-trimethyl-2*H*-naphtho1,8-*bc*furan-2-one                                                                                                        C~20~H~27~O~5~      \[M − H\]^−^    347.18491                                                    347.18530                  1.123                  329(63), 303(3), 301(100), 285(3), 187(1)
  **62**            88.91                  (3,4,5,8)-Methyl-5-(2-(furan-3-yl)ethyl)-3-hydroxy-5,8a-dimethyl-3,4,4,5,6,7,8,8a-octahydronaphthalene-1-carboxylate \*                                                                                                                                    C~20~H~27~O~4~      \[M − H\]^−^    331.19016                                                    331.19038                  0.664                  313(9), 287(15), 285(100), 283(30), 271(2), 257(5), 243(2), 237(0.4)
  **63**            95.27                  Tinotufolin C                                                                                                                                                                                                                                              C~21~H~31~O~5~      \[M − H\]^−^    363.21662                                                    363.21660                  −0.055                 345(0.1), 334(0.2), 317(69), 295(100)

^a^ Comparison with standards. \* Tentatively identified as new compounds.
